Zobrazeno 1 - 10
of 95
pro vyhledávání: '"Rongxi, Yang"'
Autor:
Lanfei Bi, Jialie Jin, Yao Fan, Yu Liu, Haifeng Xu, Mengxia Li, Changying Chen, Chong Shen, Rongxi Yang
Publikováno v:
Clinical Epigenetics, Vol 16, Iss 1, Pp 1-14 (2024)
Abstract Background Coronary heart disease (CHD) and stroke have become the leading cause of premature mortality and morbidity worldwide. Therefore, sensitive and accurate biomarkers for early detection of CHD and stroke are urgently needed for effec
Externí odkaz:
https://doaj.org/article/018fa79381d8444ea325563146ee335e
Publikováno v:
Epigenetics, Vol 19, Iss 1 (2024)
Some benign and malignant breast tumours are similar in pathological morphology, which are difficult to be distinguished in clinical diagnosis. In this study, we intended to explore novel biomarkers for differential diagnosis of benign and malignant
Externí odkaz:
https://doaj.org/article/34769ccdc27d4c8dab21c5f70c2007a3
Autor:
Yunhui Qu, Xiuzhi Zhang, Rong Qiao, Feifei Di, Yakang Song, Jun Wang, Longtao Ji, Jie Zhang, Wanjian Gu, Yifei Fang, Baohui Han, Rongxi Yang, Liping Dai, Songyun Ouyang
Publikováno v:
Respiratory Research, Vol 25, Iss 1, Pp 1-15 (2024)
Abstract Background Non-small cell lung cancer (NSCLC) accounts for the vast majority of lung cancers. Early detection is crucial to reduce lung cancer-related mortality. Aberrant DNA methylation occurs early during carcinogenesis and can be detected
Externí odkaz:
https://doaj.org/article/b8003d956a4148b8bfd7804c4e7e85d1
Autor:
Jialie Jin, Xiaojing Zhao, Chao Zhu, Mengxia Li, Jinxin Wang, Yao Fan, Chunlan Liu, Chong Shen, Rongxi Yang
Publikováno v:
Clinical Epigenetics, Vol 15, Iss 1, Pp 1-13 (2023)
Abstract Background Novel molecular biomarkers for the risk assessment and early detection of coronary heart disease (CHD) are urgently needed for disease prevention. Altered methylation of ATP-binding cassette subfamily G member 1 (ABCG1) has been i
Externí odkaz:
https://doaj.org/article/53133ab24bb24dbda42946ac4057e32b
Publikováno v:
BMC Cardiovascular Disorders, Vol 22, Iss 1, Pp 1-15 (2022)
Abstract Background Early detection could significantly improve the prognosis of coronary heart disease (CHD). In-invitro diagnostic technique may provide a solution when sufficient biomarkers could be identified. Pertinent associations between blood
Externí odkaz:
https://doaj.org/article/8917d2a099ae4f02a2870056f4ab5590
Autor:
Jinyu Li, Xiajie Zhou, Lixi Li, Longtao Ji, Jiaqi Li, Yunhui Qu, Zhi Wang, Yutong Zhao, Jie Zhang, Feifei Liang, Jingjing Liu, Wanjian Gu, Rongxi Yang, Fei Ma, Liping Dai
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
PurposePrevious studies have shown that DNA methylation in peripheral blood may be associated with breast cancer (BC). To explore the association between the methylation level of the Cathepsin Z (CTSZ) gene in peripheral blood and BC, we conducted a
Externí odkaz:
https://doaj.org/article/ef6899a462a6424a8350811d8474b142
Publikováno v:
Clinical Epigenetics, Vol 15, Iss 1, Pp 1-1 (2023)
Externí odkaz:
https://doaj.org/article/26dbb005f4be49f4ab64ab3fd242d60b
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
BackgroundCoronary heart disease (CHD) brings a heavy burden to society worldwide. Novel and minimally invasive biomarkers for the risk evaluation of CHD are urgently needed. Previous study has revealed that blood-based hypomethylation of β-actin (A
Externí odkaz:
https://doaj.org/article/4d1bf82fff7f43efbe843c46d83c6904
Autor:
Chunlan Liu, Xiajie Zhou, Jialie Jin, Qiang Zhu, Lixi Li, Qiming Yin, Tian Xu, Wanjian Gu, Fei Ma, Rongxi Yang
Publikováno v:
Frontiers in Genetics, Vol 13 (2022)
Recent studies have identified DNA methylation signatures in the white blood cells as potential biomarkers for breast cancer (BC) in the European population. Here, we investigated the association between BC and blood-based methylation of cluster of d
Externí odkaz:
https://doaj.org/article/9d189181eb4f4b16b3b56a96d66e7b07
Publikováno v:
Frontiers in Genetics, Vol 13 (2022)
Background and Aims: Previous work has shown the association between blood-based methylation of coagulation factor II receptor-like 3 gene (F2RL3) and cardiovascular mortality in Caucasians. However, the diagnostic value of F2RL3 methylation for CHD
Externí odkaz:
https://doaj.org/article/715d6e97e57641cbace15da858ad1334